The authors also showed that the drugs inhibited Na+ current (i.e., VGSC functional activity) in Xenopus oocytes expressing Nav1.2, although they did not show whether the drugs inhibited endogenous VGSC activity in the prostate cancer cells. Here, SCN2A is linked to prostate carcinoma.